Algeta

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Algeta - overview

Established

1997

Location

Oslo, -, Norway

Primary Industry

Pharmaceuticals

About

Founded in 1997 and based in Norway, Algeta is an oncology company that engages in the development of targeted therapies for patients with cancer, based on its alpha-pharmaceutical platform.


Current Investors

Incitia Ventures, HealthCap, SR One

Primary Industry

Pharmaceuticals

Sub Industries

Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development

Website

www.algeta.com

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Algeta - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

Algeta - key contacts

NamePositionStart DateEnd DateVcardBio 
Chairman Of The Board Of DirectorsBM
Chairman Of The BoardBM
Chairman Of The Board Of DirectorsBM

BM Board Member

Want to see more?

Request a demo for full access to this profile

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.